“voyager-therapeutics” Archives

in
Entry Author Date Location
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact 08/07/20 Boston
Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More 08/07/20 National
AbbVie Walks From Voyager R&D Pact Spanning Alzheimer’s, Parkinson’s 08/04/20 Boston
Taysha Launches With $30M to Bring Gene Therapy to CNS Disorders 04/29/20 Texas
Acadia, Neurocrine See Stock Price Bump After Quarterly Earnings 08/02/19 San Diego
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More 05/24/19 National
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Voyager Therapeutics, AbbVie Add Parkinson’s to Gene Therapy Pact 02/22/19 Boston
Passage Bio Gets $116M As Wilson, Yamada Team Up On Gene Therapy Again 02/14/19 National
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
Neurocrine Pays $165M to Bankroll Voyager’s Gene Therapy for Parkinson’s 01/29/19 Boston
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel 11/09/18 National
Rainwater Foundation Deploys Millions Toward Rare Brain Disease, PSP 11/07/18 Texas
Creating Companies Before 35: Meet the Young Innovator Award Finalists 08/08/18 Boston
Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech 03/08/18 New York
Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More 02/23/18 National
With $69M Deal, AbbVie Turns to Voyager for an Alzheimer’s Gene Therapy 02/20/18 Boston
Bio Roundup: Wilson’s Warning, Amazon’s Health Biz, Moderna Cash & More 02/02/18 National
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More 11/03/17 National
Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s 10/31/17 Boston
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More 09/08/17 National
For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY 08/09/17 New York
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
Voyager’s Gene Therapy for Parkinson’s Shows Promise in Small Study 12/07/16 Boston
Third Rock Gets $616M to Grow New Crop of Biotech Startups 10/31/16 Boston
Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA 08/26/16 National
Pfizer Continues Gene Therapy Push With $150M Bamboo Buyout 08/01/16 Raleigh Durham
Biogen Buys Ionis Spine Disease Drug For $75M, Eyes FDA Filing 08/01/16 Boston
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Page 1 of 2 next page »